DAVIA TITUS-THOMAS: Open Payments
NPI 1184313868 · YARDLEY, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,482 in 89 payments from 11 companies in 2025. Trend: 2023 $366 · 2024 $1,025 · 2025 $1,482
Food & beverage: $1,383Education: $99
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 18 | $287 |
| Otsuka America Pharmaceutical, Inc. | 14 | $216 |
| Teva Pharmaceuticals USA, Inc. | 10 | $194 |
| Alkermes, Inc. | 12 | $183 |
| Neurocrine BioSciences, Inc. | 10 | $165 |
| E.R. Squibb & Sons, L.L.C. | 9 | $153 |
| Janssen Pharmaceuticals, Inc | 5 | $93 |
| Lundbeck LLC | 4 | $71 |
| ABBVIE INC. | 3 | $54 |
| Vanda Pharmaceuticals Inc. | 3 | $48 |
Products named: CAPLYTA, REXULTI, ARISTADA, INGREZZA, COBENFY, UZEDY, INVEGA SUSTENNA, ABILIFY MAINTENA.
Industry payments across PA — which companies pay providers there.
